“I think that Pharma's really learned that, as we say outside of the US or outside of your own walls, is sometimes where you need to look. So, as an interventional cardiologist, devices are all over the world. You got to look, as if you're developing drugs. You know, it's worldwide, and it's definitely outside of just your own scientists in your company. There's no way you could have the pipeline that you would need if you relied on your own internal pools, even no matter how good you are.”
– Dr. Daniel Simon, President of Academic & External Affairs and Chief Scientific Officer for the University Hospitals Health System (UH)
This week’s VentureFuel Visionary is Dr. Daniel Simon. He is a practicing cardiologist, the President of Academic & External Affairs and Chief Scientific Officer for the University Hospitals Health System (UH).
In this episode, we discuss the unique non-profit, for-profit model of The Oxford-Harrington Rare Disease Centre's Therapeutics Accelerator. The Accelerator is a first-of-its-kind, transatlantic initiative to identify, fund, and advance breakthrough academic discoveries to deliver new treatments for the 400 million people worldwide who suffer from rare diseases.
VentureFuel builds and accelerates innovation programs for industry leaders by helping them unlock the power of External Innovation via startup collaborations.
